Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab (Q27851587)
scientific article
Language:
Current Data About Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab
(P31) (Q13442814)
(P248)
(P698) 20978259
(P813) Sunday, November 13, 2016

(P50) (Q28321686)
(P1545) 3

(Q28321693)
(P1545) 4

(Q28321691)
(P1545) 17

(Q28321703)
(P1545) 6

(Q37066905)
(P1545) 18
(P1932) Sabine Tejpar

(Q37068027)
(P1545) 11
(P1932) Eric Van Cutsem

(Q37068887)
(P1545) 10
(P1932) Hubert Piessevaux

(Q56989591)
(P1932) Sabrina Arena
(P1545) 8

(P304) 1812-20

(P407) (Q1860)

(P433) 16

(P478) 304

(P577) Wednesday, October 27, 2010

(P921) (Q974135)

(Q188874)
(P887)

(Q420296)
(P887)

(Q108566365)
(P887)

(Q25493920)
(P887)

(P1433) (Q1470970)

(P1476) "Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab" (language: en)
(P248)
(P698) 20978259
(P813) Sunday, November 13, 2016

(P2093) Wendy De Roock
(P1545) 1

Derek J Jonker
(P1545) 2

Dongsheng Tu
(P1545) 5

Simona Lamba
(P1545) 7

Milo Frattini
(P1545) 9

Chris J O'Callaghan
(P1545) 12

Shirin Khambata-Ford
(P1545) 13

John R Zalcberg
(P1545) 14

John Simes
(P1545) 15

Christos S Karapetis
(P1545) 16

other details
description scientific article

External Links
(P356) 10.1001/JAMA.2010.1535
(P698) 20978259
(P3181) 1181210
(P5875) 47556096